Skip to main content
Premium Trial:

Request an Annual Quote

Alan Koontz, John Spreadbury, Jonathan Burbaum


Imaging software company Nonlinear Dynamics said last week that Alan Koontz, its Asia Pacific general managner, had passed away in Tokyo following a sudden heart attack on September 16. His funeral will be held September 27 at a ceremony at Pierce Brothers Valhalla Cemetery in North Hollywood, California. Inquiries should be directed to John Spreadbury, the company’s group sales and marketing director.

ActivX Biosciences has promoted Jonathan Burbaum to the newly created position of vice president for advanced technology, the La Jolla, Calif.-based company said last week. In his new position, Burbaum will be responsible for developing several proteomics platforms in the areas of high-throughput screening, capillary electrophoresis, and mass spectrometry. During his tenure as executive director for advanced technology, Burbaum helped design ActivX’s automated protein analysis system for use with the company’s activity-based chemical probes. Burbaum has worked for Pharmacopeia and Merck Research Laboratories, where he held positions in high-throughput screening technology development and basic protein science, respectively.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.